ABT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 31, 2022 in the Class Action Filed on Behalf of Abbott Laboratories Limited Shareholders

New York, New York--(Newsfile Corp. - September 13, 2022) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Abbott Laboratories (NYSE: ABT) alleging that the Company violated federal securities laws.

This lawsuit is on behalf of all persons or entities who purchased or otherwise acquired shares of Abbott common stock during the period from February 19, 2021, to June 8, 2022, inclusive.
Lead Plaintiff Deadline: October 31, 2022
No obligation or cost to you.

Learn more about your recoverable losses in ABT:
https://www.kleinstocklaw.com/pslra-1/abt-lawsuit-abbott-laboratories-loss-submission-form?id=31693&from=5

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7092/137024_494609_logo.jpg

Abbott Laboratories NEWS - ABT NEWS

CLASS ACTION CASE DETAILS: According to the filed complaint, defendants touted the strength of Abbott's infant formula brands and their contribution to the Company's sales and revenue growth, despite knowing that the facility that manufactured those products was in flagrant violations of United States Food and Drug Administration ("FDA") health, safety, and manufacturing regulations. The complaint further alleges that defendants willfully or recklessly concealed these violations from investors, even though the violations put Abbott's infant formula business in dire jeopardy and left the Company exposed to a risk of severe regulatory action, including the recall of its products and closure of the Sturgis facility. Indeed, according to the complaint, defendants received direct warnings, communications, FDA inspection reports, and consumer complaints identifying in detail the safety and regulatory violations that were rampant at the Sturgis facility.

WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Abbott you have until October 31, 2022 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased Abbott securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the ABT lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link.

ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
535 Fifth Avenue
4th Floor
New York City, NY 10017
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/137024

info